Rebriden Trademark Details

Rebriden was registered on Tuesday, July 28, 1987 and is currently owned by Sandoz Pharmaceuticals Corporation under the registration number 1449238 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 30 years ago on Monday, January 31, 1994, according to the United State Patent & Trademark Office
Word Mark Rebriden
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Sandoz Pharmaceuticals Corporation of East Hanover, NJ

View all trademarks for Sandoz Pharmaceuticals Corporation
Other Trademarks for Sandoz Pharmaceuticals Corporation
Serial Number 73637151
Registration Number 1449238
Status Date Monday, January 31, 1994
Filing Date Monday, January 31, 1994
Registration Date Tuesday, July 28, 1987
Attorney Harold Milstein

Correspondent

HAROLD MILSTEIN
SANDOZ CORPORATION
59 ROUTE 10
EAST HANOVER, NEW JERSEY 07936

Case File Statements

Goods & Services Pharmaceutical Preparation for Use in the Treatment of Hypertension, Angina and Congestive Heart Failure

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 018
Status 2 — Sec. 8 – Entire Registration
Status Date Monday, January 31, 1994
First Use Anywhere Thursday, November 6, 1986
First Use In Commerce Thursday, November 6, 1986
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.